<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01916642</url>
  </required_header>
  <id_info>
    <org_study_id>1.1</org_study_id>
    <nct_id>NCT01916642</nct_id>
  </id_info>
  <brief_title>A Dose-response Study of Lidocaine and Etomidate</brief_title>
  <official_title>Can Intravenous Lidocaine Decrease the Minimal Inducing Dose of Etomidate?: A Randomized Placebo-controlled Dose-response Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      IV lidocaine administration can reduce the minimal amount of Etomidate and time for induction
      of anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was carried out in West China Hospital of Sichuan University, Chengdu, China. All
      the patients were informed in detail about the procedure and the medications they are going
      to get. Patients are well informed about the beneficial and possible hazards of the medicines
      and procedure. Patients are also informed that they can withdraw from the study at any time
      if they find it uncomfortable or harmful for them. Patients' written informed consent was
      obtained and registered for the permission from the Hospital's Ethics Board.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in blood pressure and heart rate.</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Etomidate Overdose of Undetermined Intent</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% Normal Saline is given instead of Lidocaine in the same volume and duration. Then, Etomidate 2mg intravenously every 15 seconds is given until the complete loss of consciousness as detected as the complete loss of eyelash reflex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine 1mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 1mg/kg is given intravenously within 2 minutes. Then, Etomidate 2mg intravenously every 15 seconds is given until the complete loss of consciousness as detected as the complete loss of eyelash reflex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine 1.5mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 1.5mg/kg is given intravenously within 2 minutes. Then, Etomidate 2mg intravenously every 15 seconds is given until the complete loss of consciousness as detected as the complete loss of eyelash reflex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine 2mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 2mg/kg is given intravenously within 2 minutes. Then, Etomidate 2mg intravenously every 15 seconds is given until the complete loss of consciousness as detected as the complete loss of eyelash reflex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine 2.5mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 2.5mg/kg is given intravenously within 2 minutes. Then, Etomidate 2mg intravenously every 15 seconds is given until the complete loss of consciousness as detected as the complete loss of eyelash reflex.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1mg/kg</intervention_name>
    <description>The total dosage of Etomidate needed for induction of anesthesia is recorded at last.</description>
    <arm_group_label>Lidocaine 1mg/kg</arm_group_label>
    <other_name>Lidocaine</other_name>
    <other_name>serial number:1303E11</other_name>
    <other_name>Etomidate-Lipuro</other_name>
    <other_name>serial number:11215033</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1.5mg/kg</intervention_name>
    <description>same as other</description>
    <arm_group_label>Lidocaine 1.5mg/kg</arm_group_label>
    <other_name>Lidocaine</other_name>
    <other_name>serial number:1303E11</other_name>
    <other_name>Etomidate-Lipuro</other_name>
    <other_name>serial number:11215033</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 2mg/kg</intervention_name>
    <description>same as other</description>
    <arm_group_label>Lidocaine 2mg/kg</arm_group_label>
    <other_name>Lidocaine</other_name>
    <other_name>serial number:1303E11</other_name>
    <other_name>Etomidate-Lipuro</other_name>
    <other_name>serial number:11215033</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 2.5mg/kg</intervention_name>
    <description>same as other</description>
    <arm_group_label>Lidocaine 2.5mg/kg</arm_group_label>
    <other_name>Lidocaine</other_name>
    <other_name>serial number:1303E11</other_name>
    <other_name>Etomidate-Lipuro</other_name>
    <other_name>serial number:11215033</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients scheduled for Elective Surgery,

          2. age limit within 18-70 years,

          3. American Society of Anaesthesiologists physical status classification I-II

        Exclusion Criteria:

          1. Adrenal Cortex disorder,

          2. Neurologic disease,

          3. Psychiatric disorders,

          4. Allergic to Local anesthetic drugs,

          5. Patients who have received sedatives,analgesics or opioids within the previous 24 hrs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liu Jin, MD</last_name>
    <role>Study Director</role>
    <affiliation>West China Hospital</affiliation>
  </overall_official>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2013</study_first_posted>
  <last_update_submitted>August 1, 2013</last_update_submitted>
  <last_update_submitted_qc>August 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Niharika Dhakal</investigator_full_name>
    <investigator_title>Resident,Department of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>iv lidocaine</keyword>
  <keyword>inducing dose</keyword>
  <keyword>etomidate</keyword>
  <keyword>dose response</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

